Compare Aether Industri. with Similar Stocks
Dashboard
Company has a low Debt to Equity ratio (avg) at 0.02 times
Healthy long term growth as Net Sales has grown by an annual rate of 21.16% and Operating profit at 26.18%
With a growth in Net Profit of 19.5%, the company declared Outstanding results in Dec 25
Majority shareholders : Promoters
Stock DNA
Specialty Chemicals
INR 13,305 Cr (Small Cap)
58.00
38
0.00%
0.07
8.71%
5.61
Total Returns (Price + Dividend) 
Aether Industri. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Aether Industries Ltd Upgraded to Buy on Strong Financials and Bullish Technicals
Aether Industries Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, improving technical momentum, and attractive growth prospects despite a premium valuation. This article analyses the key factors driving the rating change and what investors should consider going forward.
Read full news article
Aether Industries Ltd Technical Momentum Shifts Signal Bullish Outlook
Aether Industries Ltd, a key player in the specialty chemicals sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent dip in price, the company’s technical indicators, including MACD, RSI, and moving averages, suggest strengthening momentum that could underpin future gains amid a challenging market backdrop.
Read full news article
Aether Industries Ltd Opens with Significant Gap Down Amid Market Concerns
Aether Industries Ltd, a key player in the Specialty Chemicals sector, opened the trading session on 9 Mar 2026 with a pronounced gap down, reflecting heightened market concerns. The stock declined sharply by 9.88% at the open, signalling a weak start and triggering notable volatility throughout the day.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04-Mar-2026 | Source : BSEIn accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time we hereby submit the schedule of Meetings with Investors with Company Officials at Company premises in Surat as annexed.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04-Mar-2026 | Source : BSEIn accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time we hereby submit the schedule of the Companys participation in Investor Conference to be convened in Singapore as annexed.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
25-Feb-2026 | Source : BSEFurther with reference to the intimation dated February 16 2026 submitted vide Ref. No. AIL/SE/65/2025-26 in accordance with Regulation 30 and all other applicable provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended this is to inform you that Company Officials had Meetings in person during Investor Conferences in Mumbai as annexed.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 12 Schemes (11.07%)
Held by 81 FIIs (5.81%)
Purnima Ashwin Desai (17.4%)
Sbi Multicap Fund (8.63%)
5.43%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 13.22% vs 9.35% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 19.50% vs 14.76% in Sep 2025






